13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:52:49 UTC, with 88 holding rows worth $2,409,466,201.
- Accession
- 0001420506-26-002894
- Filer
- CIK 1920938
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 88 entries on the cover page, a total value of $2,409,466,201 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,409,466,201 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KODIAK SCIENCES INC | 50015M109 | COM | 1,085,743 | $102,928,436 | dollars as filed | |
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 2,746,688 | $84,131,053 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,069,091 | $84,005,095 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 7,228,839 | $74,601,618 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 640,562 | $72,806,277 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAD4 | NOTE 0.750% 3/1 | 69,121,000 | $69,329,620 | dollars as filed | principal |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 655,306 | $63,721,955 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 713,957 | $63,563,592 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,708,435 | $63,536,698 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 3,348,502 | $61,478,497 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 343,873 | $56,460,508 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,726,693 | $55,754,917 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 654,178 | $54,591,154 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 125,957 | $51,217,895 | dollars as filed | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 3,870,106 | $48,028,015 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 336,571 | $47,739,231 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 518,398 | $45,644,944 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 802,472 | $45,540,286 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 2,962,249 | $44,492,980 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 5,503,086 | $42,153,639 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 114,077 | $37,937,447 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,352,693 | $37,199,058 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 1,747,659 | $37,190,184 | dollars as filed | |
| ALAMAR BIOSCIENCES INC | 010911105 | COMMON STOCK | 1,083,983 | $36,931,301 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 300,569 | $33,600,609 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 1,573,823 | $33,239,142 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 2,863,350 | $32,842,625 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 464,470 | $32,215,639 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 141,504 | $31,350,211 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,149,735 | $31,249,797 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 81,399 | $31,059,416 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 2,526,009 | $30,135,287 | dollars as filed | |
| Teva Pharmaceutical Industries Ltd | M8769Q102 | Common / Ordinary Stock | 753,537 | $29,840,065 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 41,675 | $28,132,709 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 906,115 | $27,446,223 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 443,591 | $26,857,217 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 319,679 | $26,626,064 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 587,567 | $25,647,300 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 59,900 | $24,757,269 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 3,084,022 | $24,672,176 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,609,392 | $24,671,979 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,100,370 | $24,505,240 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 255,828 | $24,358,663 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 483,822 | $24,104,012 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 398,951 | $23,386,508 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,931,402 | $22,249,751 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 111,500 | $21,433,645 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 744,460 | $21,209,665 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 902,815 | $21,198,096 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 117,910 | $21,030,428 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 871,104 | $20,653,876 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 502,508 | $17,854,109 | dollars as filed | |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 18,011,000 | $16,926,138 | dollars as filed | principal |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 6,582,421 | $16,390,228 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 49,560 | $13,648,328 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 990,959 | $13,348,218 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 328,240 | $12,844,031 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 400,913 | $12,837,234 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 795,214 | $12,723,424 | dollars as filed | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 975,385 | $11,733,882 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,652,991 | $11,036,443 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 335,206 | $10,786,929 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 905,731 | $10,189,474 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 1,068,883 | $9,983,367 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 481,489 | $9,711,633 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 900,000 | $9,468,000 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 40,400 | $9,416,028 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,753,978 | $9,225,924 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 371,102 | $8,642,966 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 176,462 | $7,879,028 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 19,440 | $7,558,661 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 331,400 | $7,463,128 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 700,000 | $7,455,000 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 1,033,129 | $7,324,885 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 2,344,822 | $6,799,984 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 319,308 | $6,092,397 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 645,110 | $5,999,523 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 300,000 | $5,982,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 226,652 | $5,475,912 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 400,000 | $4,284,000 | dollars as filed | |
| JATT III ACQUISITION CORP | G5080G109 | COM | 350,000 | $3,906,000 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 225,000 | $3,856,500 | dollars as filed | |
| RESEARCH ALLIANCE CORP IV | G75228109 | CL A ORD SHS | 300,000 | $3,552,000 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 41,100 | $2,913,579 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 250,000 | $2,780,000 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 752,541 | $1,437,353 | dollars as filed | |
| KORSANA BIOSCIENCES INC | 23255M303 | COMMON STOCK | 43,042 | $1,377,344 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 584,412 | $1,104,539 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002894 | this filing | 2026-11-16 |